Q4 2024 Holdings
Filed 2025-02-13 | 26 holdings | $1.6B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Spdr S&P 500 ETF TR(SPY)Put | TR UNIT | 78462F103 | $442.5M | 755,000 | 27.0% |
| QXO Inc(QXO) | COM NEW | 82846H405 | $396.4M | 24,933,825 | 24.2% |
| Ishares TR(IWM)Put | RUSSELL 2000 ETF | 464287655 | $328.1M | 1,485,000 | 20.0% |
| Liberty Broadband Corp(LBRDK) | COM SER C | 530307305 | $150.7M | 2,015,710 | 9.2% |
| Liberty Media Corp del(LLYVK*) | COM LBTY LIV S C | 531229722 | $55.3M | 812,792 | 3.4% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $32.6M | 52,928 | 2.0% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $31.1M | 710,260 | 1.9% |
| Springworks Therapeutics Inc | COM | 85205L107 | $27.1M | 748,752 | 1.7% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $25.5M | 184,872 | 1.6% |
| MoonLake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $24.3M | 447,935 | 1.5% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $19.7M | 161,935 | 1.2% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $18.6M | 674,762 | 1.1% |
| Xencor Inc(XNCR) | COM | 98401F105 | $15.2M | 660,000 | 0.9% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $15.0M | 318,448 | 0.9% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $13.7M | 713,778 | 0.8% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $11.4M | 391,300 | 0.7% |
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $9.1M | 657,071 | 0.6% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $9.0M | 2,175,646 | 0.5% |
| Eyepoint Pharmaceuticals Inc(EYPT) | COM NEW | 30233G209 | $8.3M | 1,111,104 | 0.5% |
| Solid Biosciences Inc(SLDB) | COM NEW | 83422E204 | $3.8M | 961,251 | 0.2% |
| Aleanna Inc(ANNA) | COM CL A | 01444V103 | $196.8K | 27,717 | 0.0% |
| Aleanna Inc(ANNAW) | *W EXP 12/13/202 | 01444V111 | $68.6K | 490,000 | 0.0% |
| Moneyhero Limited | *W EXP 09/13/202 | G6202B119 | $49.4K | 895,000 | 0.0% |
| Lakeshore Biopharma Co LTD | *W EXP 03/15/202 | G9845F117 | $48.5K | 489,999 | 0.0% |
| Marblegate Acquisition Corp | *W EXP 08/31/202 | 56608A113 | $25.7K | 735,000 | 0.0% |
| Calidi Biotherapeutics Inc | COM NEW | 320703309 | $14.4K | 12,500 | 0.0% |